![Jeffrey Silber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Silber
Chief Tech/Sci/R&D Officer at
IRONWOOD PHARMACEUTICALS, INC.
Net worth: 579 662 $ as of 30/07/2026
Profile
Jeffrey Silber is Chief Medical Officer at Ironwood Pharmaceuticals, Inc. since 2026.
Dr. Silber was Chief Medical Officer at Vedanta Biosciences, Inc. from 2020 to 2026.
Dr. Silber completed undergraduate studies at Harvard University and earned a doctorate from Albert Einstein College of Medicine, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/07/2026 | 137,036 ( 0.08% ) | 579 662 $ | 30/07/2026 |
Jeffrey Silber active positions
| Companies | Position | Start |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 19/07/2026 |
Former positions of Jeffrey Silber
| Companies | Position | End |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Chief Tech/Sci/R&D Officer | 30/06/2026 |
Training of Jeffrey Silber
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
- Stock Market
- Insiders
- Jeffrey Silber
